Alumis is currently recruiting patients to participate in the ONWARD clinical study. The trial is seeking to enroll patients with plaque psoriasis to help evaluate efficacy and safety of an investigational oral TYK2 inhibitor, ESK-001. Psoriasis can be painful to live with and affect your quality of life. Atossa hopes to bring relief through this study.
View the clinical study site here - https://www.onwardclinicalstudy.com/
Connect
with us
Connect with us
Connect
with us
About Us
Trial AMPlify is a leading clinical trial patient recruitment agency solely focused on driving subject enrollment through innovative outreach campaigns, world-class clinical trial website design and analytics for Biotech, Life Science, Pharma firms.
*Examining the Current Value of ClinicalTrials.gov Listings for Patients and
the Public - Applied Clinical Trials August 12, 2023
^Clinical trial facts and percentages - National Institutes of Health NIH.gov
©2025 All rights reserved.
Trial
AMPlify
is a division of
Boston Web Partners LLC.